21
Last reporting period 30 Jun, 2024
Updated 19 Sep, 2024
Last price
—
Market cap $B
0.161
Exchange
XHKG - Hong Kong Exchange
0.12 B
Last period Equity ,CNY
-89%
Equity has decreased in 5 years
What is Equity ?
Equity is the amount of money that the company would receive if all its assets were sold and all debt obligations were paid off.
See also Mabpharm
Company Analysis
2181.HK valuation, rating, competitors, insights and company profile
Eyestock Rating
2181.HK financial analysis by Eyestock methodology
Valuation
2181.HK valuation using historical relative method
Statements
2181.HK Income Statements, Balance Sheet and Cash Flow Statements
Dividends
2181.HK dividend yield and annual dividend
Equity is the amount of money that the company would receive if all its assets were sold and all debt obligations were paid off.
Mabpharm`s Equity for the period ended 2024-06-30 is 0.12 B CNY
